Related Experiment Video
Updated: Mar 17, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.2K
Metastatic melanoma and immunotherapy.
Benjamin Herzberg1, David E Fisher2
1Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.
Clinical Immunology (Orlando, Fla.)
|July 20, 2016
Summary
Immunotherapy harnesses the immune system to fight cancer. Immune checkpoint inhibitors targeting CTLA4 and PD1 have shown significant success in treating advanced melanoma, with potential for broader cancer applications.
Area of Science:
- Oncology
- Immunology
- Cancer Therapy
Background:
- Harnessing the immune system against cancer has been a long-standing goal in medicine.
- Recent advancements have led to significant progress in cancer immunotherapy, particularly in melanoma treatment.
Purpose of the Study:
- To review the current understanding of immune checkpoint inhibitors in advanced melanoma.
- To discuss the clinical impact and future potential of these therapies for melanoma and other cancers.
Main Methods:
- Review of current literature on immune checkpoint inhibitors (CTLA4, PD1) in melanoma.
- Analysis of clinical responses and efficacy data for advanced melanoma patients.
Main Results:
- Immune checkpoint inhibitors targeting CTLA4 and PD1 have demonstrated major clinical efficacy in advanced melanoma.
- These therapies stimulate T cell-mediated tumor killing by blocking key immune tolerance receptors.
Conclusions:
- Checkpoint blockade therapies have revolutionized melanoma treatment, offering durable responses.
- Further advancements are expected to improve immunotherapy efficacy for melanoma and less immunogenic malignancies.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
01:30Skin Cancer
6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K